Filed 3mo ago· Feb 13, 2026
14 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Biogen
BIIB
$1K-$15K
+10.0% vs S&P 500
Trade dateJan 30, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–14 of 14
Filed 12mo ago· Jun 9, 2025
25 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Biogen
BIIB
$1K-$15K
+40.3% vs S&P 500
Trade dateMay 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 8, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Biogen
BIIB
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 27, 2025
30 days to discloseRobert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Biogen
BIIB
$1K-$15K
+33.2% vs S&P 500
Trade dateFeb 25, 2025
⚑ Pharmaceutical
Filed 3.3y ago· Feb 9, 2023
17 days to disclose
Shri Thanedar
DHouseMichigan-13
↓sold
Biogen
BIIB
$50K-$100K
+78.1% vs S&P 500
Trade dateJan 23, 2023
Filed 3.5y ago· Dec 16, 2022
43 days to disclose
Susan M. Collins
RSenateMaine
↑bought
Biogen
BIIB
$15K-$50K
Trade dateNov 3, 2022
Bond⚑ Pharmaceutical
Filed 3.7y ago· Sep 14, 2022
42 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↓sold
Biogen
BIIB
$1K-$15K
+12.4% vs S&P 500
Trade dateAug 3, 2022
Filed 3.8y ago· Aug 10, 2022
26 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Biogen
BIIB
$1K-$15K
−26.2% vs S&P 500
Trade dateJul 15, 2022
Filed 4.1y ago· Apr 17, 2022
39 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↑bought
Biogen
BIIB
$1K-$15K
−20.0% vs S&P 500
Trade dateMar 9, 2022
Filed 4.3y ago· Feb 11, 2022
30 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Biogen
BIIB
$15K-$30K
−24.2% vs S&P 500
Trade dateJan 12, 2022
Filed 4.4y ago· Jan 10, 2022
32 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Biogen
BIIB
$1K-$15K
Trade dateDec 9, 2021
Filed 4.6y ago· Nov 15, 2021
28 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Biogen
BIIB
$1K-$15K
Trade dateOct 18, 2021
Filed 4.6y ago· Oct 13, 2021
42 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Biogen
BIIB
$1K-$15K
Trade dateSep 1, 2021
Filed 4.9y ago· Jul 15, 2021
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Biogen
BIIB
$1K-$15K
Trade dateJun 8, 2021
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Feb 13, 2026 3mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Biogen BIIB | Jan 30, 2026 14 days to disclose | Good buy·+$480+6.0% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Biogen BIIB ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | May 15, 2025 25 days to disclose | Good buy·+$4.3K+54.1% +40.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Biogen BIIB ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Biogen BIIB ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Good buy·+$2.6K+32.9% +33.2% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 9, 2023 3.3y ago | Shri Thanedar DHouseMichigan-13 | ↓sold | Biogen BIIB | Jan 23, 2023 17 days to disclose | Flat·+0.0% +78.1% vs S&P 500 | $50K-$100K midpoint $75K |
Dec 16, 2022 3.5y ago | Susan M. Collins RSenateMaine | ↑bought | Biogen BIIB Bond⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 3, 2022 43 days to disclose | price pending | $15K-$50K midpoint $32.5K |
Sep 14, 2022 3.7y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Biogen BIIB | Aug 3, 2022 42 days to disclose | Flat·+0.0% +12.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Biogen BIIB | Jul 15, 2022 26 days to disclose | Bad buy·−$971-12.1% −26.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2022 4.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Biogen BIIB | Mar 9, 2022 39 days to disclose | Bad buy·−$458-5.7% −20.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2022 4.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Biogen BIIB | Jan 12, 2022 30 days to disclose | Bad buy·−$3.5K-15.4% −24.2% vs S&P 500 | $15K-$30K midpoint $22.5K |
Jan 10, 2022 4.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Biogen BIIB | Dec 9, 2021 32 days to disclose | price pending | $1K-$15K midpoint $8K |
Nov 15, 2021 4.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Biogen BIIB | Oct 18, 2021 28 days to disclose | price pending | $1K-$15K midpoint $8K |
Oct 13, 2021 4.6y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Biogen BIIB | Sep 1, 2021 42 days to disclose | price pending | $1K-$15K midpoint $8K |
Jul 15, 2021 4.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Biogen BIIB | Jun 8, 2021 37 days to disclose | price pending | $1K-$15K midpoint $8K |